Progressive multiple sclerosis, cognitive function, and quality of life

Cognitive function alone is a poor predictor of health-related quality of life in employed patients with MS: results from a cross-sectional study

(2016) Ambra Mara Giovannetti et al.   CLINICAL NEUROPSYCHOLOGIST

High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial

(2016) Karen Schreiber et al.   Multiple Sclerosis Journal

High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial

(2016) Karen Schreiber et al.   Multiple Sclerosis Journal

Lowering the Floor on Trail Making Test Part B: Psychometric Evidence for a New Scoring Metric

(2015) Stephen Correia et al.   ARCHIVES OF CLINICAL NEUROPSYCHOLOGY

A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity

(2015) Mariana López-Góngora et al.   BMC Neurology

Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing−remitting, secondary progressive and primary progressive multiple sclerosis

(2015) V. Planche et al.   EUROPEAN JOURNAL OF NEUROLOGY

Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives

(2015) Daniel Ontaneda et al.   LANCET NEUROLOGY

The effects of robot-assisted gait training in progressive multiple sclerosis: A randomized controlled trial

(2015) Sofia Straudi et al.   Multiple Sclerosis Journal

Trail Making Test: Normative data for the Latin American Spanish speaking adult population

(2015) J.C. Arango-Lasprilla et al.   NEUROREHABILITATION

The effects of robot-assisted gait training in progressive multiple sclerosis: A randomized controlled trial

(2015) Sofia Straudi et al.   Multiple Sclerosis Journal

Eye and hand motor interactions with the Symbol Digit Modalities Test in early multiple sclerosis

(2015) Gro O. Nygaard et al.   Multiple Sclerosis and Related Disorders

The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis

(2014) J. Van Schependom et al.   EUROPEAN JOURNAL OF NEUROLOGY

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2014) F. D. Lublin et al.   NEUROLOGY

Treatment trials in progressive MS—current challenges and future directions

(2013) Marcus W. Koch et al.   Nature Reviews Neurology

Cognitive impairment differs between primary progressive and relapsing-remitting MS

(2013) A. Ruet et al.   NEUROLOGY

Natalizumab Treatment Reduces Fatigue in Multiple Sclerosis. Results from the TYNERGY Trial; A Study in the Real Life Setting

(2013) Anders Svenningsson et al.   PLoS One

Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)

(2011) DW Langdon et al.   Multiple Sclerosis Journal

Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS

(2009) L Strober et al.   Multiple Sclerosis Journal

Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test

(2009) AS Drake et al.   Multiple Sclerosis Journal

Oralmotor slowing in multiple sclerosis: Relationship to neuropsychological tasks requiring an oral response

(2008) PETER A. ARNETT et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET

Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study

(2008) B Brochet et al.   Multiple Sclerosis Journal